Mason MD - Search Results

1

A novel tumor antigen derived from enhanced degradation of bax protein in human cancers.

Nunes CT, Miners KL, Dolton G, Pepper C, Fegan C, Mason MD, Man S. Nunes CT, et al. Among authors: mason md. Cancer Res. 2011 Aug 15;71(16):5435-44. doi: 10.1158/0008-5472.CAN-11-0393. Epub 2011 Jun 22. Cancer Res. 2011. PMID: 21697278 Free article.

2

Expansion of a CD8(+)PD-1(+) replicative senescence phenotype in early stage CLL patients is associated with inverted CD4:CD8 ratios and disease progression.

Nunes C, Wong R, Mason M, Fegan C, Man S, Pepper C. Nunes C, et al. Clin Cancer Res. 2012 Feb 1;18(3):678-87. doi: 10.1158/1078-0432.CCR-11-2630. Epub 2011 Dec 21. Clin Cancer Res. 2012. PMID: 22190592

3

Human tumor-derived exosomes selectively impair lymphocyte responses to interleukin-2.

Clayton A, Mitchell JP, Court J, Mason MD, Tabi Z. Clayton A, et al. Among authors: mason md. Cancer Res. 2007 Aug 1;67(15):7458-66. doi: 10.1158/0008-5472.CAN-06-3456. Cancer Res. 2007. PMID: 17671216

4

Cross-Presentation of the Oncofetal Tumor Antigen 5T4 from Irradiated Prostate Cancer Cells--A Key Role for Heat-Shock Protein 70 and Receptor CD91.

Salimu J, Spary LK, Al-Taei S, Clayton A, Mason MD, Staffurth J, Tabi Z. Salimu J, et al. Among authors: mason md. Cancer Immunol Res. 2015 Jun;3(6):678-88. doi: 10.1158/2326-6066.CIR-14-0079. Epub 2015 Feb 12. Cancer Immunol Res. 2015. PMID: 25678582

5

Clinical studies of human papilloma vaccines in cervical cancer.

Adams M, Borysiewicz L, Fiander A, Man S, Jasani B, Navabi H, Evans AS, Mason M. Adams M, et al. Adv Exp Med Biol. 2001;495:419-27. doi: 10.1007/978-1-4615-0685-0_61. Adv Exp Med Biol. 2001. PMID: 11774604 No abstract available.

6

Clinical studies of human papilloma vaccines in pre-invasive and invasive cancer.

Adams M, Borysiewicz L, Fiander A, Man S, Jasani B, Navabi H, Lipetz C, Evans AS, Mason M. Adams M, et al. Vaccine. 2001 Mar 21;19(17-19):2549-56. doi: 10.1016/s0264-410x(00)00488-6. Vaccine. 2001. PMID: 11257391 Review.

7

Matriptase-2 inhibits breast tumor growth and invasion and correlates with favorable prognosis for breast cancer patients.

Parr C, Sanders AJ, Davies G, Martin T, Lane J, Mason MD, Mansel RE, Jiang WG. Parr C, et al. Among authors: mason md. Clin Cancer Res. 2007 Jun 15;13(12):3568-76. doi: 10.1158/1078-0432.CCR-06-2357. Clin Cancer Res. 2007. PMID: 17575220

8

Dendritic cell (DC) based therapy for cervical cancer: use of DC pulsed with tumour lysate and matured with a novel synthetic clinically non-toxic double stranded RNA analogue poly [I]:poly [C(12)U] (Ampligen R).

Adams M, Navabi H, Jasani B, Man S, Fiander A, Evans AS, Donninger C, Mason M. Adams M, et al. Vaccine. 2003 Jan 30;21(7-8):787-90. doi: 10.1016/s0264-410x(02)00599-6. Vaccine. 2003. PMID: 12531360 Review.

9

Targeting matrilysin and its impact on tumor growth in vivo: the potential implications in breast cancer therapy.

Jiang WG, Davies G, Martin TA, Parr C, Watkins G, Mason MD, Mokbel K, Mansel RE. Jiang WG, et al. Among authors: mason md. Clin Cancer Res. 2005 Aug 15;11(16):6012-9. doi: 10.1158/1078-0432.CCR-05-0275. Clin Cancer Res. 2005. PMID: 16115946

10

Overexpression and potential targeting of the oncofoetal antigen 5T4 in malignant pleural mesothelioma.

Al-Taei S, Salimu J, Lester JF, Linnane S, Goonewardena M, Harrop R, Mason MD, Tabi Z. Al-Taei S, et al. Among authors: mason md. Lung Cancer. 2012 Aug;77(2):312-8. doi: 10.1016/j.lungcan.2012.03.008. Epub 2012 Apr 10. Lung Cancer. 2012. PMID: 22498111 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

283 results

Search Page

Filters